Trade SION stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Sionna Therapeutics, Inc. (SION) is trading at US$5.96, down 16.99% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$239.17M. Over the past 52 weeks, SION has traded between US$4.01 and US$54.97. On Syfe you can trade SION with $0 commission and add it to your watchlist.
| Previous close | US$7.18 |
|---|---|
| Market cap | US$239.17M |
| 52-week range | US$4.01 – US$54.97 |
| Volume | 3.67M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.
Year: 2025
Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says
Aug 12, 3:02 PM · MT Newswires
BTIG Downgrades Sionna Therapeutics to Neutral From Buy
Aug 11, 11:36 AM · MT Newswires
Top Midday Decliners
Aug 10, 7:10 PM · MT Newswires
Sector Update: Healthcare Stocks Rise in Afternoon Trading
Aug 10, 5:40 PM · MT Newswires
Sionna Therapeutics, Inc. (SION) stock is trading at US$5.96, -16.99% from the previous close of US$7.18.
The market cap for Sionna Therapeutics, Inc. (SION) stock is approximately US$239.17M.
The 52-week high for Sionna Therapeutics, Inc. (SION) stock is US$54.97.
The 52-week low for Sionna Therapeutics, Inc. (SION) stock is US$4.01.
Sionna Therapeutics, Inc. (SION) does not currently pay a dividend.
Stay on top of SION
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
